Your browser doesn't support javascript.
loading
Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors.
Oei, Vincent Yi Sheng; Siernicka, Marta; Graczyk-Jarzynka, Agnieszka; Hoel, Hanna Julie; Yang, Weiwen; Palacios, Daniel; Almåsbak, Hilde; Bajor, Malgorzata; Clement, Dennis; Brandt, Ludwig; Önfelt, Björn; Goodridge, Jodie; Winiarska, Magdalena; Zagozdzon, Radoslaw; Olweus, Johanna; Kyte, Jon-Amund; Malmberg, Karl-Johan.
Afiliación
  • Oei VYS; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
  • Siernicka M; The KG Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Graczyk-Jarzynka A; Department of Immunology, Centre for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
  • Hoel HJ; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland.
  • Yang W; Department of Immunology, Centre for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
  • Palacios D; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
  • Almåsbak H; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
  • Bajor M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
  • Clement D; The KG Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Brandt L; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
  • Önfelt B; Department of Immunology, Centre for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
  • Goodridge J; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
  • Winiarska M; The KG Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Zagozdzon R; Science for Life Laboratory, Department of Applied Physics, KTH-Royal Institute of Technology, Solna, Sweden.
  • Olweus J; Science for Life Laboratory, Department of Applied Physics, KTH-Royal Institute of Technology, Solna, Sweden.
  • Kyte JA; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Malmberg KJ; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Norway.
Cancer Immunol Res ; 6(4): 467-480, 2018 04.
Article en En | MEDLINE | ID: mdl-29459477
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Receptores de Antígenos de Linfocitos T / Subgrupos Linfocitarios / Receptores Quiméricos de Antígenos Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Año: 2018 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Receptores de Antígenos de Linfocitos T / Subgrupos Linfocitarios / Receptores Quiméricos de Antígenos Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Año: 2018 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Estados Unidos